Intrahepatic Cholangiocarcinoma Market is driven by personalized medicine breakthroughs
The Intrahepatic Cholangiocarcinoma Market comprises therapeutic agents and diagnostic tools designed to detect and treat bile duct cancer occurring within the liver. Products in this space include targeted small‐molecule inhibitors, monoclonal antibodies, and advanced imaging systems coupled with companion diagnostics that enable precision oncology. These solutions offer significant advantages...
0 Comentários 0 Compartilhamentos 88 Visualizações 0 Anterior